Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9225 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.9147 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8947 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8947 |
High Similarity |
NPD1613 |
Approved |
0.8722 |
High Similarity |
NPD3027 |
Phase 3 |
0.8647 |
High Similarity |
NPD4908 |
Phase 1 |
0.8519 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8231 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8092 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8029 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8013 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7962 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7959 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7868 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7868 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7852 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7843 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD228 |
Approved |
0.7794 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.777 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7748 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7746 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7744 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7744 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7742 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7716 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.771 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7667 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7658 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7609 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7591 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7562 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7538 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7538 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7463 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7452 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7445 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7445 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7439 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7434 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7413 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7328 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7325 |
Intermediate Similarity |
NPD37 |
Approved |
0.7323 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7317 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7317 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7317 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7308 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7305 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7296 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7296 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7296 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD846 |
Approved |
0.7266 |
Intermediate Similarity |
NPD940 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7239 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7239 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7237 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7233 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7211 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7203 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7181 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7171 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD943 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7121 |
Intermediate Similarity |
NPD290 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7114 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7105 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7091 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7078 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7045 |
Intermediate Similarity |
NPD968 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7019 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7014 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7013 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7006 |
Intermediate Similarity |
NPD5403 |
Approved |
0.6993 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD3060 |
Approved |
0.6987 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.6986 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD5735 |
Approved |
0.698 |
Remote Similarity |
NPD4340 |
Discontinued |
0.698 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6959 |
Remote Similarity |
NPD4578 |
Approved |
0.6959 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD4577 |
Approved |
0.6957 |
Remote Similarity |
NPD7819 |
Suspended |
0.6948 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD6696 |
Suspended |
0.6943 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6936 |
Remote Similarity |
NPD4663 |
Approved |
0.6933 |
Remote Similarity |
NPD1607 |
Approved |
0.6933 |
Remote Similarity |
NPD4055 |
Discovery |
0.6928 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD1608 |
Approved |
0.6918 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6903 |
Remote Similarity |
NPD2219 |
Phase 1 |
0.6903 |
Remote Similarity |
NPD2677 |
Approved |
0.6897 |
Remote Similarity |
NPD7906 |
Approved |
0.6894 |
Remote Similarity |
NPD6801 |
Discontinued |
0.6892 |
Remote Similarity |
NPD3268 |
Approved |
0.6887 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6887 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6886 |
Remote Similarity |
NPD27 |
Approved |
0.6886 |
Remote Similarity |
NPD2489 |
Approved |
0.6883 |
Remote Similarity |
NPD4237 |
Approved |
0.6883 |
Remote Similarity |
NPD4162 |
Approved |
0.6883
|
Remote Similarity |
NPD4236 |
Phase 3 |